Access to medicines in the context of the right-to-health framework 2013, para. 28
Paragraph
Paragraph text
In contrast to cost-based pricing, market-based pricing fixes the maximum retail price through an "average" formula for all brands in a therapeutic category that have a specific market share. Market-based pricing therefore tends to cap the price of medicines at the middle range between the highest and lowest price, making medicines more expensive in comparison to cost-based pricing.
Legal status
Non-negotiated soft law
Body
Special Rapporteur on the right of everyone to the enjoyment of the highest attainable standard of physical and mental health
Document type
Special Procedures' report
Means of adoption
N.A.
Topic(s)
Health
Person(s) affected
N.A.
Year
2013
Paragraph type
Other
Reference
SR Health, Report to the HRC (2013), A/HRC/23/42, para. 28.